AllianceBernstein
CDMO

AllianceBernstein’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

AllianceBernstein’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,186,003
Closed -$14.6M – 3259
2024
Q4 		$14.6M Buy
1,186,003
+1,110,443
+1,470% +$12.7M 0.01% 1011
2024
Q3 		$860K Hold
75,560
– – ﹤0.01% 2395
2024
Q2 		$539K Buy
75,560
+16,010
+27% +$122K ﹤0.01% 2631
2024
Q1 		$399K Sell
59,550
-7,900
-12% -$54.4K ﹤0.01% 2679
2023
Q4 		$438K Buy
67,450
+7,250
+12% +$46.7K ﹤0.01% 2673
2023
Q3 		$568K Hold
60,200
– – ﹤0.01% 2509
2023
Q2 		$841K Hold
60,200
– – ﹤0.01% 2365
2023
Q1 		$1.13M Sell
60,200
-9,175
-13% -$151K ﹤0.01% 2166
2022
Q4 		$955K Buy
69,375
+104
+0.2% +$1.59K ﹤0.01% 2307
2022
Q3 		$1.32M Buy
69,271
+1,393
+2% +$25.4K ﹤0.01% 2141
2022
Q2 		$1.04M Buy
67,878
+109
+0.2% +$1.61K ﹤0.01% 2333
2022
Q1 		$1.38M Sell
67,769
-4,675
-6% -$95.2K ﹤0.01% 2300
2021
Q4 		$2.11M Sell
72,444
-26,356
-27% -$754K ﹤0.01% 2113
2021
Q3 		$2.13M Buy
98,800
+40,000
+68% +$966K ﹤0.01% 2135
2021
Q2 		$1.51M Hold
58,800
– – ﹤0.01% 2341
2021
Q1 		$1.07M Sell
58,800
-40,840
-41% -$679K ﹤0.01% 2382
2020
Q4 		$1.15M Buy
99,640
+28,340
+40% +$259K ﹤0.01% 2233
2020
Q3 		$543K Hold
71,300
– – ﹤0.01% 2488
2020
Q2 		$468K Buy
71,300
+18,500
+35% +$103K ﹤0.01% 2654
2020
Q1 		$270K Buy
52,800
+10,100
+24% +$61.1K ﹤0.01% 2670
2019
Q4 		$328K Hold
42,700
– – ﹤0.01% 2742
2019
Q3 		$226K Buy
42,700
+14,100
+49% +$87.5K ﹤0.01% 2903
2019
Q2 		$160K Buy
28,600
+3,400
+13% +$14K ﹤0.01% 3013
2019
Q1 		$107K Buy
25,200
+9,900
+65% +$40.4K ﹤0.01% 3005
2018
Q4 		$63K Buy
15,300
+2,600
+20% +$13.6K ﹤0.01% 3038
2018
Q3 		$87K Buy
+12,700
New +$75.3K ﹤0.01% 3092
2016
Q2 		– Sell
-3,714
Closed -$11K – 3004
2016
Q1 		$11K Hold
3,714
– – ﹤0.01% 2910
2015
Q4 		$30K Hold
3,714
– – ﹤0.01% 2902
2015
Q3 		$27K Hold
3,714
– – ﹤0.01% 2930
2015
Q2 		$34K Buy
3,714
+2,085
+128% +$20K ﹤0.01% 2989
2015
Q1 		$15K Hold
1,629
– – ﹤0.01% 3311
2014
Q4 		$16K Hold
1,629
– – ﹤0.01% 3259
2014
Q3 		$16K Sell
1,629
-1,628
-50% -$18.2K ﹤0.01% 3231
2014
Q2 		$43K Buy
3,257
+3,070
+1,642% +$38.7K ﹤0.01% 3130
2014
Q1 		$2K Sell
187
-2,543
-93% -$33.5K ﹤0.01% 3461
2013
Q4 		$27K Sell
2,730
-6,257
-70% -$58.9K ﹤0.01% 3047
2013
Q3 		$89K Sell
8,987
-236
-3% -$2.34K ﹤0.01% 2993
2013
Q2 		$83K Buy
+9,223
New +$96.7K ﹤0.01% 2963

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AllianceBernstein's CDMO Position: Q1 2025 in Review

AllianceBernstein sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 1,186,003 shares — an estimated $14.6M sold.

AllianceBernstein first reported a position in CDMO in Q2 2013 and held it in 38 quarters. The position peaked at $14.6M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • AllianceBernstein reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • AllianceBernstein sold 1,186,003 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $14.6M.
  • AllianceBernstein first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
  • AllianceBernstein's Avid Bioservices, Inc. Common Stock position peaked at $14.6M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on AllianceBernstein's 13F filing for Q1 2025, filed 15 May 2025.